Project description:Parental and 5-fluorouracil (5-FU)-resistant HCT15 cells were treated with 5-FU or vehicle for 12h and assembled into an IMPRINTS-CETSA scheme with 6 different heating temperatures (37ºC, 47ºC, 50ºC, 52ºC, 54ºC, and 57ºC) with each set of samples heated at one temperature included in the same isobaric TMT10 set and measured at the same time on the mass spectrometer.
This entry contains two datasets:
1. 5-FU in parental vs. resistant HCT15 (file names “12h 5FU_par vs resHCT15”) for data referred to as HCT15_Par_5FU and HCT15_Res_5FU in the associated publication. The labelling order of samples in the TMT10 channels for this dataset was as follows: 37C/47C/50C/52C/54C/57C samples: Biorep1_Parental_Vehicle (126), Biorep1_Parental_5FU_100µM (127N), Biorep1_Resistant_5FU_16µM (127C), Biorep2_ Parental_Vehicle (128N), Biorep2_ Parental_5FU_100µM (128C), Biorep2_ Resistant_5FU_16µM (129N), Biorep3_ Parental_Vehicle (129C), Biorep3_ Parental_5FU_100µM (130N), Biorep3_ Resistant_5FU_16µM (130C), mixed_control (131).
2. 5-FU in resistant HCT15 (file names “12h 5FU_ResHCT15_diff”) for data referred to as HCT15_Res_Diff in the in the associated publication. The labelling order of samples in the TMT10 channels for this dataset was as follows: 37C/47C/50C/52C/54C/57C samples: Biorep1_ Resistant_5FU_16µM (128N), Biorep2_ Resistant_5FU_16µM (128C), Biorep3_ Resistant_5FU_16µM (129N), Biorep1_ Resistant_5FU_100µM (129C), Biorep2_ Resistant_5FU_100µM (130N), Biorep3_ Resistant_5FU_100µM (130C), mixed_control (131).
For additional details see the methods section of the associated publication.
Project description:MCF7 cells were treated with floxuridine (FUDR), fluorouridine (FUR), or vehicle and assembled into an IMPRINTS-CETSA scheme with 6 different heating temperatures (37ºC, 47ºC, 50ºC, 52ºC, 54ºC, and 57ºC) with each set of samples heated at one temperature included in the same isobaric TMT10 set and measured at the same time on the mass spectrometer.
This entry contains two IMPRINTS-CETSA datasets:
1. MCF7 incubated with Vehicle/FUDR/FUR for 2 hours
2. MCF7 incubated with Vehicle/FUDR/FUR for 12 hours
The labelling order of samples in the TMT10 channels for both datasets was as follows: 37C/47C/50C/52C/54C/57C samples: Biorep1_Vehicle (126), Biorep1_FUDR (127N), Biorep1_FUR (127C), Biorep2_Vehicle (128N), Biorep2_FUDR (128C), Biorep2_FUR (129N), Biorep3_Vehicle (129C), Biorep3_FUDR (130N), Biorep3_FUR (130C), mixed_control (131).
For additional details see the methods section of the associated publication.
Project description:MCF7 xenograft-bearing mice were treated intravenously for 22h with either vehicle or different 5-FU doses (10, 50, 100, and 150 mg/kg). Each xenograft was cut in similar-sized pieces and assembled into an ITDRCETSA scheme with 2 different heating temperatures (37ºC, 52ºC) and 3 xenograft pieces for each temperature. The ITDRCETSA samples were labelled using TMT10-plex.
The labelling order of samples in the TMT10 channels for was as follows: Tumour pieces 1, 2, and 3: Vehicle_52C (126), 10mg/kg_52C (127N), 50mg/kg_52C (127C), 100mg/kg_52C (128N), 150mg/kg_52C (128C), Vehicle_37C (129N), 10mg/kg_37C (129C), 50mg/kg_37C (130N), 100mg/kg_37C (130C), 150mg/kg_37C (131).
For additional details see the methods section of the associated publication.
Project description:IMPRINTS-CETSA data acquisition of Kasumi-1 cells treated with Vehicle (DMSO), Venetoclax, Decitabine, Azacitidine and Azacitidine+Venetoclax using TMT 16 plex.
Project description:IMPRINTS-CETSA data acquisition of Kasumi-1 cells treated with Vehicle (DMSO), Venetoclax, Decitabine, Azacitidine and Azacitidine+Venetoclax using TMT 16 plex.
Project description:Amplificaition of HOXD9 and HOXD13 genes was found in MWCNTs induced carcinogencity. By overexpression or silence of of HOXD9 and HOXD13 gene may alter tumorigenicity. To investigate the realted signaling pathways invovled in HOXD regulated tumorigencity, we analyzed the gene expression profile of the HOXD9 or HOXD13 overexpression HEK293 cells, which compared to vehicle expressing cells HEK293 cells was transfected with HA-tag-HOXD9 and V5-tag HOXD13 vector, and further selected by G418. Three independnent clones and mix clones of each genes were selected, and compared to corresponding tag control cell. (HA-HOXD9-mix, a, b, c v.s HA-MOCK-1, 2, 3) (V5-HOXD13-mix, a, b, c v.s V5-MOCK-1, 2, 3)